120 related articles for article (PubMed ID: 1567480)
1. Metabolism and RNA incorporation of cyclopentenyl cytosine in human colorectal cancer cells.
Yee LK; Allegra CJ; Trepel JB; Grem JL
Biochem Pharmacol; 1992 Apr; 43(7):1587-99. PubMed ID: 1567480
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
Blaney SM; Grem JL; Balis FM; Cole DE; Adamson PC; Poplack DG
Biochem Pharmacol; 1993 Apr; 45(7):1493-501. PubMed ID: 8471071
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
Grem JL; Allegra CJ
Cancer Res; 1990 Nov; 50(22):7279-84. PubMed ID: 1699659
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity and metabolism of 4-methoxy-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine in HCT 116 colon cancer cells.
Grem JL; Daychild P; Drake J; Geoffroy F; Trepel JB; Pirnia F; Allegra CJ
Biochem Pharmacol; 1994 Nov; 48(11):2117-26. PubMed ID: 7528507
[TBL] [Abstract][Full Text] [Related]
5. Cyclopentenyl cytidine analogue. An inhibitor of cytidine triphosphate synthesis in human colon carcinoma cells.
Glazer RI; Knode MC; Lim MI; Marquez VE
Biochem Pharmacol; 1985 Jul; 34(14):2535-9. PubMed ID: 4015694
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells.
Bouffard DY; Momparler LF; Momparler RL
Anticancer Drugs; 1994 Apr; 5(2):223-8. PubMed ID: 7519483
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical trial of continuous infusion cyclopentenyl cytosine.
Politi PM; Xie F; Dahut W; Ford H; Kelley JA; Bastian A; Setser A; Allegra CJ; Chen AP; Hamilton JM
Cancer Chemother Pharmacol; 1995; 36(6):513-23. PubMed ID: 7554044
[TBL] [Abstract][Full Text] [Related]
8. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.
Verschuur AC; Van Gennip AH; Leen R; Voûte PA; Brinkman J; Van Kuilenburg AB
Int J Cancer; 2002 Apr; 98(4):616-23. PubMed ID: 11920624
[TBL] [Abstract][Full Text] [Related]
9. The effect of ara-C-induced inhibition of DNA synthesis on its cellular pharmacology.
Wang LM; White JC; Capizzi RL
Cancer Chemother Pharmacol; 1990; 25(6):418-24. PubMed ID: 2311169
[TBL] [Abstract][Full Text] [Related]
10. Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.
Zhang H; Cooney DA; Zhang MH; Ahluwalia G; Ford H; Johns DG
Cancer Res; 1993 Dec; 53(23):5714-20. PubMed ID: 7694793
[TBL] [Abstract][Full Text] [Related]
11. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
[TBL] [Abstract][Full Text] [Related]
12. Interaction of deoxyuridine with fluorouracil and dipyridamole in a human colon cancer cell line.
Grem JL; Mulcahy RT; Miller EM; Allegra CJ; Fischer PH
Biochem Pharmacol; 1989 Jan; 38(1):51-9. PubMed ID: 2462882
[TBL] [Abstract][Full Text] [Related]
13. Studies on the antitumor activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo.
Gharehbaghi K; Zhen W; Fritzer-Szekeres M; Szekeres T; Jayaram HN
Life Sci; 1999; 64(2):103-12. PubMed ID: 10069488
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of cytidine dialdehyde and its effects on nucleotide and nucleic acid synthesis.
Kinahan JJ; Pavelic ZP; Leonard RJ; Bloch A; Grindey GB
Cancer Res; 1980 Mar; 40(3):598-603. PubMed ID: 7471080
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia.
Verschuur AC; Van Gennip AH; Leen R; Meinsma R; Voute PA; van Kuilenburg AB
Br J Haematol; 2000 Jul; 110(1):161-9. PubMed ID: 10930994
[TBL] [Abstract][Full Text] [Related]
16. Reversal by cytidine of cyclopentenyl cytosine-induced toxicity in mice without compromise of antitumor activity.
Ford H; Driscoll JS; Hao Z; Dobyns KA; Rommel ME; Stowe E; Anderson JO; Plowman J; Waud WR; Johns DG
Biochem Pharmacol; 1995 Jan; 49(2):173-80. PubMed ID: 7840794
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity and biochemical effects of cyclopentenyl cytosine in mice.
Moyer JD; Malinowski NM; Treanor SP; Marquez VE
Cancer Res; 1986 Jul; 46(7):3325-9. PubMed ID: 3708566
[TBL] [Abstract][Full Text] [Related]
18. Determinants of trimetrexate lethality in human colon cancer cells.
Grem JL; Voeller DM; Geoffroy F; Horak E; Johnston PG; Allegra CJ
Br J Cancer; 1994 Dec; 70(6):1075-84. PubMed ID: 7981057
[TBL] [Abstract][Full Text] [Related]
19. DUP 785 (NSC 368390): schedule-dependency of growth-inhibitory and antipyrimidine effects.
Schwartsmann G; Peters GJ; Laurensse E; de Waal FC; Loonen AH; Leyva A; Pinedo HM
Biochem Pharmacol; 1988 Sep; 37(17):3257-66. PubMed ID: 2840910
[TBL] [Abstract][Full Text] [Related]
20. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
Grem JL; Geoffroy F; Politi PM; Cuddy DP; Ross DD; Nguyen D; Steinberg SM; Allegra CJ
Mol Pharmacol; 1995 Aug; 48(2):305-15. PubMed ID: 7651364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
